New Life Pharma recalls 15mg x 4 Tirzepatide injections due to lack of sterility assurance. Affected lots may cause infections if used.
Lack of Assurance of Sterility
New Life Pharma is recalling 15mg x 4 Tirzepatide injections because they may not be sterile. This could lead to infections if the product is used.
The vials may not be sterile, which can lead to infections if the product is used. This is a risk for people who have been prescribed the medication.
People with prescriptions for Tirzepatide injections from New Life Pharma. Those using the recalled vials are at risk of infection.
Check for the product name 'Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial' with the lot number 240709 and expiration date 7/31/2026.
Look for the lot number 240709 and expiration date 7/31/2026 on the vial.
The recall states there is a lack of sterility assurance, so it may not be safe to use. Consult your healthcare provider.
Check for the lot number 240709 and expiration date 7/31/2026 on the vial.
The recall does not specify a remedy, so contact New Life Pharma directly for guidance.
We’ve drafted a message you can send New Life Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0395-2026 — New Life Pharma New Life Pharma Hello, I own a New Life Pharma that is covered by recall D-0395-2026 from New Life Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
+ 1 more story
